A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
Please note that all translations are automatically generated. Click here for the English version.
3.5K Views
•
10:46 min
•
September 13th, 2022
DOI :
September 13th, 2022
•Rozdziały w tym wideo
0:05
Introduction
1:02
Binding Assay
4:10
Flow Cytometry and Data Analysis
8:58
Results: Flow Cytometric-Based Assay to Study the Binding of an Aptamer and Cancer Cells
9:55
Conclusion
Powiązane Filmy
07:36
Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
5.2K Views
13:59
High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds
1.9K Views
13:19
Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
2.5K Views
11:14
Primer-Free Aptamer Selection Using A Random DNA Library
24.7K Views
09:39
Assessing Specificity of Anticancer Drugs In Vitro
9.4K Views
08:46
A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
53.2K Views
12:23
In Vitro Selection of Aptamers to Differentiate Infectious from Non-Infectious Viruses
1.6K Views
05:21
Assessing Antibody-dependent, Cell-mediated Cytotoxicity in Cancer Cells using Antibody-Dependent Cell-Mediated Cytotoxicity Reporter Bioassay
282 Views
12:31
A Method for Selecting Structure-switching Aptamers Applied to a Colorimetric Gold Nanoparticle Assay
15.1K Views
08:09
Droplet-based Cytotoxicity Assay to Assess Chimeric Antigen Receptor T cells at the Single-cell Level
741 Views
Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone